Advertisement

Digestive Diseases and Sciences

, Volume 62, Issue 6, pp 1561–1570 | Cite as

Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults

  • Sang Pyo Lee
  • Sun-Young Lee
  • Jeong Hwan Kim
  • In-Kyung Sung
  • Hyung Seok Park
  • Chan Sup Shim
Original Article

Abstract

Background and Aim

Upper gastrointestinal (UGI) symptoms are common; however, the role of Helicobacter pylori and gastric corpus atrophy in the generation of these symptoms is controversial. The aim of this study was to determine the risk factors for UGI symptoms in adults in an endemic area of H. pylori infection.

Methods

Korean adults who completed questionnaires on the day of serum anti-H. pylori IgG and pepsinogen (PG) assays before UGI endoscopy were included. Gastric corpus atrophy was based on the criteria of a serum PG I/II ratio <3.0 and a PG I <70 ng/ml.

Results

Of the 2275 included subjects, 723 (31.8%) had at least one UGI symptom. A total of 374 (16.4%) subjects had multiple symptoms without significant correlations between the symptoms (λ < 0.2). The H. pylori serology assay was positive in 1382 (60.7%) subjects, and gastric corpus atrophy was present in 291 (12.8%). Neither H. pylori seropositivity (p = 0.077) nor gastric corpus atrophy (p = 0.138) was related to the presence of UGI symptoms. Female gender and smoking were independent risk factors for heartburn and upper abdominal pain (all p < 0.001). Furthermore, female gender was the only independent risk factor for multiple UGI symptoms (p < 0.001), globus sensation (p < 0.001), early satiety (p < 0.001), epigastric soreness (p = 0.001), and chest discomfort (p = 0.003).

Conclusions

In an H. pylori seroprevalent population, female gender is the most common risk factor followed by smoking for UGI symptom generation. Neither H. pylori seropositivity nor gastric corpus atrophy is an independent risk factor for UGI symptom generation.

Keywords

Upper gastrointestinal symptom Helicobacter pylori Gastric atrophy Female 

Notes

Acknowledgments

This study was supported by Konkuk University in 2015.

Compliance with ethical standards

Conflict of interest

None.

Supplementary material

10620_2017_4529_MOESM1_ESM.docx (24 kb)
Supplementary material 1 (DOCX 24 kb)

References

  1. 1.
    Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049–1057.CrossRefPubMedGoogle Scholar
  2. 2.
    Fang YJ, Liou JM, Chen CC, et al. Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. Gut. 2015;64:1517–1528.CrossRefPubMedGoogle Scholar
  3. 3.
    Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil. 2015;21:273–282.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Tahara T, Arisawa T, Shibata T, et al. Association of endoscopic appearances with dyspeptic symptoms. J Gastroenterol. 2008;43:208–215.CrossRefPubMedGoogle Scholar
  5. 5.
    Iwai W, Abe Y, Iijima K, et al. Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients. J Gastroenterol. 2013;48:214–221.CrossRefPubMedGoogle Scholar
  6. 6.
    Wei Z, Ying L, Wen G, Mengnan Z, Yali Z. Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients. Helicobacter. 2014;19:124–128.CrossRefPubMedGoogle Scholar
  7. 7.
    D’Elios MM, Czinn SJ. Immunity, inflammation, and vaccines for Helicobacter pylori. Helicobacter. 2014;19:19–26.CrossRefPubMedGoogle Scholar
  8. 8.
    Liu Y, Vosmaer GD, Tytgat GN, Xiao SD, Ten Kate FJ. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. J Clin Pathol. 2005;58:927–931.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lee SY. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J Intern Med. 2016;31:835–844.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol. 2005;40:938–944.CrossRefPubMedGoogle Scholar
  11. 11.
    Mizuno S, Miki I, Ishida T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132–3137. doi: 10.1007/s10620-010-1154-0.CrossRefPubMedGoogle Scholar
  12. 12.
    Eshmuratov A, Nah JC, Kim N, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55:1364–1375. doi: 10.1007/s10620-009-0891-4.CrossRefPubMedGoogle Scholar
  13. 13.
    Choi HS, Lee SY, Kim JH, et al. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. J Dig Dis. 2014;15:293–298.CrossRefPubMedGoogle Scholar
  14. 14.
    Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol. 2001;16:969–975.CrossRefPubMedGoogle Scholar
  15. 15.
    Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther. 2003;17:297–305.CrossRefPubMedGoogle Scholar
  16. 16.
    Konturek PC, Konturek SJ, Sito E, et al. Luminal Nalpha-methyl histamine stimulates gastric acid secretion in duodenal ulcer patients via releasing gastrin. Eur J Pharmacol. 2001;412:181–185.CrossRefPubMedGoogle Scholar
  17. 17.
    Kawakubo H, Tanaka Y, Tsuruoka N, et al. Upper gastrointestinal symptoms are more frequent in female than male young healthy Japanese volunteers as evaluated by questionnaire. J Neurogastroenterol Motil. 2016;22:248–253.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Mirbagheri SS, Mirbagheri SA, Nabavizadeh B, et al. Impact of microscopic duodenitis on symptomatic response to Helicobacter pylori eradication in functional dyspepsia. Dig Dis Sci. 2015;60:163–167. doi: 10.1007/s10620-014-3285-1.CrossRefPubMedGoogle Scholar
  19. 19.
    Miwa H, Hirai S, Nagahara A, et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients—a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2000;14:317–324.CrossRefPubMedGoogle Scholar
  20. 20.
    Bode G, Brenner H, Adler G, Rothenbacher D. Dyspeptic symptoms in middle-aged to old adults: the role of Helicobacter pylori infection, and various demographic and lifestyle factors. J Intern Med. 2002;252:41–47.CrossRefPubMedGoogle Scholar
  21. 21.
    Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine—a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:536–544.CrossRefPubMedGoogle Scholar
  22. 22.
    Fujiwara Y, Kubo M, Kohata Y, et al. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. Intern Med. 2011;50:2443–2447.CrossRefPubMedGoogle Scholar
  23. 23.
    Matsuzaki J, Suzuki H, Kobayakawa M, et al. Association of visceral fat area, smoking, and alcohol consumption with reflux esophagitis and Barrett’s esophagus in Japan. PLoS One. 2015;10:e0133865.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Yap PR, Goh KL. Non-steroidal anti-inflammatory drugs (NSAIDs) induced dyspepsia. Curr Pharm Des. 2015;21:5073–5081.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Internal MedicineKonkuk University School of MedicineSeoulKorea

Personalised recommendations